171 related articles for article (PubMed ID: 38104236)
1. Unveiling the molecular basis of lobeline's allosteric regulation of NMDAR: insights from molecular modeling.
Remya C; Variyar EJ; Omkumar RV; Sadasivan C; Dileep KV
Sci Rep; 2023 Dec; 13(1):22418. PubMed ID: 38104236
[TBL] [Abstract][Full Text] [Related]
2. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
[TBL] [Abstract][Full Text] [Related]
3. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
4. The discovery of subunit-selective GluN1/GluN2B NMDAR antagonist via pharmacophere-based virtual screening.
Tang J; Jin J; Huang Z; An F; Huang C; Jiang W
Exp Biol Med (Maywood); 2023 Dec; 248(24):2560-2577. PubMed ID: 38282535
[TBL] [Abstract][Full Text] [Related]
5. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
Mazumder MK; Borah A
Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
[TBL] [Abstract][Full Text] [Related]
7. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
8. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Karakas E; Simorowski N; Furukawa H
Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
10. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
11. Lobeline: A multifunctional alkaloid modulates cholinergic and glutamatergic activities.
Remya C; Dileep KV; Variyar EJ; Omkumar RV; Sadasivan C
IUBMB Life; 2023 Oct; 75(10):844-855. PubMed ID: 37335270
[TBL] [Abstract][Full Text] [Related]
12. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
13. Design and synthesis of novel GluN2A NMDAR positive allosteric modulators via scaffold hopping strategy as anti-stroke therapeutic agents.
Chen X; Zhu H; Liu X; Li Q; Dong M
Bioorg Med Chem; 2023 Apr; 83():117236. PubMed ID: 36934527
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
Izumi Y; Zorumski CF
J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
Kane LT; Costa BM
J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.
Zhou X; Ding Q; Chen Z; Yun H; Wang H
J Biol Chem; 2013 Aug; 288(33):24151-9. PubMed ID: 23839940
[TBL] [Abstract][Full Text] [Related]
17. Identifying potential GluN2B subunit containing N-Methyl-D-aspartate receptor inhibitors: an integrative
Singh R; Ganeshpurkar A; Kumar D; Kumar D; Kumar A; Singh SK
J Biomol Struct Dyn; 2020 Jun; 38(9):2533-2545. PubMed ID: 31232189
[TBL] [Abstract][Full Text] [Related]
18. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
Yu SP; Jiang MQ; Shim SS; Pourkhodadad S; Wei L
Mol Neurodegener; 2023 Jul; 18(1):43. PubMed ID: 37400870
[TBL] [Abstract][Full Text] [Related]
19. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.
Hrcka Krausova B; Kysilov B; Cerny J; Vyklicky V; Smejkalova T; Ladislav M; Balik A; Korinek M; Chodounska H; Kudova E; Vyklicky L
J Neurosci; 2020 Jul; 40(31):5922-5936. PubMed ID: 32611707
[No Abstract] [Full Text] [Related]
20. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
